Copyright Reports & Markets. All rights reserved.

Global Asthma Reliever (Rescue) Medications Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application

Request for Sample of this report
Buy now

Table of Contents

    1 Asthma Reliever (Rescue) Medications Market Overview

    • 1.1 Asthma Reliever (Rescue) Medications Product Overview
    • 1.2 Asthma Reliever (Rescue) Medications Market Segment by Type
      • 1.2.1 Quick-Relief Medications
      • 1.2.2 Long-Term Control Medications
    • 1.3 Global Asthma Reliever (Rescue) Medications Market Size by Type
      • 1.3.1 Global Asthma Reliever (Rescue) Medications Market Size Overview by Type (2017-2028)
      • 1.3.2 Global Asthma Reliever (Rescue) Medications Historic Market Size Review by Type (2017-2022)
        • 1.3.2.1 Global Asthma Reliever (Rescue) Medications Sales Breakdown in Volume by Type (2017-2022)
        • 1.3.2.2 Global Asthma Reliever (Rescue) Medications Sales Breakdown in Value by Type (2017-2022)
        • 1.3.2.3 Global Asthma Reliever (Rescue) Medications Average Selling Price (ASP) by Type (2017-2022)
      • 1.3.3 Global Asthma Reliever (Rescue) Medications Forecasted Market Size by Type (2023-2028)
        • 1.3.3.1 Global Asthma Reliever (Rescue) Medications Sales Breakdown in Volume by Type (2023-2028)
        • 1.3.3.2 Global Asthma Reliever (Rescue) Medications Sales Breakdown in Value by Type (2023-2028)
        • 1.3.3.3 Global Asthma Reliever (Rescue) Medications Average Selling Price (ASP) by Type (2023-2028)
    • 1.4 Key Regions Market Size Segment by Type
      • 1.4.1 North America Asthma Reliever (Rescue) Medications Sales Breakdown by Type (2017-2022)
      • 1.4.2 Europe Asthma Reliever (Rescue) Medications Sales Breakdown by Type (2017-2022)
      • 1.4.3 Asia-Pacific Asthma Reliever (Rescue) Medications Sales Breakdown by Type (2017-2022)
      • 1.4.4 Latin America Asthma Reliever (Rescue) Medications Sales Breakdown by Type (2017-2022)
      • 1.4.5 Middle East and Africa Asthma Reliever (Rescue) Medications Sales Breakdown by Type (2017-2022)

    2 Global Asthma Reliever (Rescue) Medications Market Competition by Company

    • 2.1 Global Top Players by Asthma Reliever (Rescue) Medications Sales (2017-2022)
    • 2.2 Global Top Players by Asthma Reliever (Rescue) Medications Revenue (2017-2022)
    • 2.3 Global Top Players Asthma Reliever (Rescue) Medications Price (2017-2022)
    • 2.4 Global Top Manufacturers Asthma Reliever (Rescue) Medications Manufacturing Base Distribution, Sales Area, Product Type
    • 2.5 Asthma Reliever (Rescue) Medications Market Competitive Situation and Trends
      • 2.5.1 Asthma Reliever (Rescue) Medications Market Concentration Rate (2017-2022)
      • 2.5.2 Global 5 and 10 Largest Manufacturers by Asthma Reliever (Rescue) Medications Sales and Revenue in 2021
    • 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asthma Reliever (Rescue) Medications as of 2021)
    • 2.7 Date of Key Manufacturers Enter into Asthma Reliever (Rescue) Medications Market
    • 2.8 Key Manufacturers Asthma Reliever (Rescue) Medications Product Offered
    • 2.9 Mergers & Acquisitions, Expansion

    3 Asthma Reliever (Rescue) Medications Status and Outlook by Region

    • 3.1 Global Asthma Reliever (Rescue) Medications Market Size and CAGR by Region: 2017 VS 2021 VS 2028
    • 3.2 Global Asthma Reliever (Rescue) Medications Historic Market Size by Region
      • 3.2.1 Global Asthma Reliever (Rescue) Medications Sales in Volume by Region (2017-2022)
      • 3.2.2 Global Asthma Reliever (Rescue) Medications Sales in Value by Region (2017-2022)
      • 3.2.3 Global Asthma Reliever (Rescue) Medications Sales (Volume & Value) Price and Gross Margin (2017-2022)
    • 3.3 Global Asthma Reliever (Rescue) Medications Forecasted Market Size by Region
      • 3.3.1 Global Asthma Reliever (Rescue) Medications Sales in Volume by Region (2023-2028)
      • 3.3.2 Global Asthma Reliever (Rescue) Medications Sales in Value by Region (2023-2028)
      • 3.3.3 Global Asthma Reliever (Rescue) Medications Sales (Volume & Value), Price and Gross Margin (2023-2028)

    4 Global Asthma Reliever (Rescue) Medications by Application

    • 4.1 Asthma Reliever (Rescue) Medications Market Segment by Application
      • 4.1.1 Children
      • 4.1.2 Adolescent
      • 4.1.3 Adult
    • 4.2 Global Asthma Reliever (Rescue) Medications Market Size by Application
      • 4.2.1 Global Asthma Reliever (Rescue) Medications Market Size Overview by Application (2017-2028)
      • 4.2.2 Global Asthma Reliever (Rescue) Medications Historic Market Size Review by Application (2017-2022)
        • 4.2.2.1 Global Asthma Reliever (Rescue) Medications Sales Breakdown in Volume, by Application (2017-2022)
        • 4.2.2.2 Global Asthma Reliever (Rescue) Medications Sales Breakdown in Value, by Application (2017-2022)
        • 4.2.2.3 Global Asthma Reliever (Rescue) Medications Average Selling Price (ASP) by Application (2017-2022)
      • 4.2.3 Global Asthma Reliever (Rescue) Medications Forecasted Market Size by Application (2023-2028)
        • 4.2.3.1 Global Asthma Reliever (Rescue) Medications Sales Breakdown in Volume, by Application (2023-2028)
        • 4.2.3.2 Global Asthma Reliever (Rescue) Medications Sales Breakdown in Value, by Application (2023-2028)
        • 4.2.3.3 Global Asthma Reliever (Rescue) Medications Average Selling Price (ASP) by Application (2023-2028)
    • 4.3 Key Regions Market Size Segment by Application
      • 4.3.1 North America Asthma Reliever (Rescue) Medications Sales Breakdown by Application (2017-2022)
      • 4.3.2 Europe Asthma Reliever (Rescue) Medications Sales Breakdown by Application (2017-2022)
      • 4.3.3 Asia-Pacific Asthma Reliever (Rescue) Medications Sales Breakdown by Application (2017-2022)
      • 4.3.4 Latin America Asthma Reliever (Rescue) Medications Sales Breakdown by Application (2017-2022)
      • 4.3.5 Middle East and Africa Asthma Reliever (Rescue) Medications Sales Breakdown by Application (2017-2022)

    5 North America Asthma Reliever (Rescue) Medications by Country

    • 5.1 North America Asthma Reliever (Rescue) Medications Historic Market Size by Country
      • 5.1.1 North America Asthma Reliever (Rescue) Medications Sales in Volume by Country (2017-2022)
      • 5.1.2 North America Asthma Reliever (Rescue) Medications Sales in Value by Country (2017-2022)
    • 5.2 North America Asthma Reliever (Rescue) Medications Forecasted Market Size by Country
      • 5.2.1 North America Asthma Reliever (Rescue) Medications Sales in Volume by Country (2023-2028)
      • 5.2.2 North America Asthma Reliever (Rescue) Medications Sales in Value by Country (2023-2028)

    6 Europe Asthma Reliever (Rescue) Medications by Country

    • 6.1 Europe Asthma Reliever (Rescue) Medications Historic Market Size by Country
      • 6.1.1 Europe Asthma Reliever (Rescue) Medications Sales in Volume by Country (2017-2022)
      • 6.1.2 Europe Asthma Reliever (Rescue) Medications Sales in Value by Country (2017-2022)
    • 6.2 Europe Asthma Reliever (Rescue) Medications Forecasted Market Size by Country
      • 6.2.1 Europe Asthma Reliever (Rescue) Medications Sales in Volume by Country (2023-2028)
      • 6.2.2 Europe Asthma Reliever (Rescue) Medications Sales in Value by Country (2023-2028)

    7 Asia-Pacific Asthma Reliever (Rescue) Medications by Region

    • 7.1 Asia-Pacific Asthma Reliever (Rescue) Medications Historic Market Size by Region
      • 7.1.1 Asia-Pacific Asthma Reliever (Rescue) Medications Sales in Volume by Region (2017-2022)
      • 7.1.2 Asia-Pacific Asthma Reliever (Rescue) Medications Sales in Value by Region (2017-2022)
    • 7.2 Asia-Pacific Asthma Reliever (Rescue) Medications Forecasted Market Size by Region
      • 7.2.1 Asia-Pacific Asthma Reliever (Rescue) Medications Sales in Volume by Region (2023-2028)
      • 7.2.2 Asia-Pacific Asthma Reliever (Rescue) Medications Sales in Value by Region (2023-2028)

    8 Latin America Asthma Reliever (Rescue) Medications by Country

    • 8.1 Latin America Asthma Reliever (Rescue) Medications Historic Market Size by Country
      • 8.1.1 Latin America Asthma Reliever (Rescue) Medications Sales in Volume by Country (2017-2022)
      • 8.1.2 Latin America Asthma Reliever (Rescue) Medications Sales in Value by Country (2017-2022)
    • 8.2 Latin America Asthma Reliever (Rescue) Medications Forecasted Market Size by Country
      • 8.2.1 Latin America Asthma Reliever (Rescue) Medications Sales in Volume by Country (2023-2028)
      • 8.2.2 Latin America Asthma Reliever (Rescue) Medications Sales in Value by Country (2023-2028)

    9 Middle East and Africa Asthma Reliever (Rescue) Medications by Country

    • 9.1 Middle East and Africa Asthma Reliever (Rescue) Medications Historic Market Size by Country
      • 9.1.1 Middle East and Africa Asthma Reliever (Rescue) Medications Sales in Volume by Country (2017-2022)
      • 9.1.2 Middle East and Africa Asthma Reliever (Rescue) Medications Sales in Value by Country (2017-2022)
    • 9.2 Middle East and Africa Asthma Reliever (Rescue) Medications Forecasted Market Size by Country
      • 9.2.1 Middle East and Africa Asthma Reliever (Rescue) Medications Sales in Volume by Country (2023-2028)
      • 9.2.2 Middle East and Africa Asthma Reliever (Rescue) Medications Sales in Value by Country (2023-2028)

    10 Company Profiles and Key Figures in Asthma Reliever (Rescue) Medications Business

    • 10.1 Dulera
      • 10.1.1 Dulera Corporation Information
      • 10.1.2 Dulera Introduction and Business Overview
      • 10.1.3 Dulera Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.1.4 Dulera Asthma Reliever (Rescue) Medications Products Offered
      • 10.1.5 Dulera Recent Development
    • 10.2 QVAR
      • 10.2.1 QVAR Corporation Information
      • 10.2.2 QVAR Introduction and Business Overview
      • 10.2.3 QVAR Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.2.4 QVAR Asthma Reliever (Rescue) Medications Products Offered
      • 10.2.5 QVAR Recent Development
    • 10.3 Glaxosmithkline plc
      • 10.3.1 Glaxosmithkline plc Corporation Information
      • 10.3.2 Glaxosmithkline plc Introduction and Business Overview
      • 10.3.3 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.3.4 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Products Offered
      • 10.3.5 Glaxosmithkline plc Recent Development
    • 10.4 MAP Pharmaceuticals，Inc
      • 10.4.1 MAP Pharmaceuticals，Inc Corporation Information
      • 10.4.2 MAP Pharmaceuticals，Inc Introduction and Business Overview
      • 10.4.3 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.4.4 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Products Offered
      • 10.4.5 MAP Pharmaceuticals，Inc Recent Development
    • 10.5 Merck & Co. Inc
      • 10.5.1 Merck & Co. Inc Corporation Information
      • 10.5.2 Merck & Co. Inc Introduction and Business Overview
      • 10.5.3 Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.5.4 Merck & Co. Inc Asthma Reliever (Rescue) Medications Products Offered
      • 10.5.5 Merck & Co. Inc Recent Development
    • 10.6 AstraZeneca plc
      • 10.6.1 AstraZeneca plc Corporation Information
      • 10.6.2 AstraZeneca plc Introduction and Business Overview
      • 10.6.3 AstraZeneca plc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.6.4 AstraZeneca plc Asthma Reliever (Rescue) Medications Products Offered
      • 10.6.5 AstraZeneca plc Recent Development
    • 10.7 Roche Holdings Ltd
      • 10.7.1 Roche Holdings Ltd Corporation Information
      • 10.7.2 Roche Holdings Ltd Introduction and Business Overview
      • 10.7.3 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.7.4 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Products Offered
      • 10.7.5 Roche Holdings Ltd Recent Development
    • 10.8 Genentech Inc
      • 10.8.1 Genentech Inc Corporation Information
      • 10.8.2 Genentech Inc Introduction and Business Overview
      • 10.8.3 Genentech Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.8.4 Genentech Inc Asthma Reliever (Rescue) Medications Products Offered
      • 10.8.5 Genentech Inc Recent Development
    • 10.9 Sepracor, Inc
      • 10.9.1 Sepracor, Inc Corporation Information
      • 10.9.2 Sepracor, Inc Introduction and Business Overview
      • 10.9.3 Sepracor, Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.9.4 Sepracor, Inc Asthma Reliever (Rescue) Medications Products Offered
      • 10.9.5 Sepracor, Inc Recent Development
    • 10.10 Schering-Plough Corp
      • 10.10.1 Schering-Plough Corp Corporation Information
      • 10.10.2 Schering-Plough Corp Introduction and Business Overview
      • 10.10.3 Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.10.4 Schering-Plough Corp Asthma Reliever (Rescue) Medications Products Offered
      • 10.10.5 Schering-Plough Corp Recent Development
    • 10.11 Sanofi-Aventis
      • 10.11.1 Sanofi-Aventis Corporation Information
      • 10.11.2 Sanofi-Aventis Introduction and Business Overview
      • 10.11.3 Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.11.4 Sanofi-Aventis Asthma Reliever (Rescue) Medications Products Offered
      • 10.11.5 Sanofi-Aventis Recent Development
    • 10.12 Theravance Inc
      • 10.12.1 Theravance Inc Corporation Information
      • 10.12.2 Theravance Inc Introduction and Business Overview
      • 10.12.3 Theravance Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2017-2022)
      • 10.12.4 Theravance Inc Asthma Reliever (Rescue) Medications Products Offered
      • 10.12.5 Theravance Inc Recent Development

    11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

    • 11.1 Asthma Reliever (Rescue) Medications Key Raw Materials
      • 11.1.1 Key Raw Materials
      • 11.1.2 Key Raw Materials Price
      • 11.1.3 Raw Materials Key Suppliers
    • 11.2 Manufacturing Cost Structure
      • 11.2.1 Raw Materials
      • 11.2.2 Labor Cost
      • 11.2.3 Manufacturing Expenses
    • 11.3 Asthma Reliever (Rescue) Medications Industrial Chain Analysis
    • 11.4 Asthma Reliever (Rescue) Medications Market Dynamics
      • 11.4.1 Asthma Reliever (Rescue) Medications Industry Trends
      • 11.4.2 Asthma Reliever (Rescue) Medications Market Drivers
      • 11.4.3 Asthma Reliever (Rescue) Medications Market Challenges
      • 11.4.4 Asthma Reliever (Rescue) Medications Market Restraints

    12 Market Strategy Analysis, Distributors

    • 12.1 Sales Channel
    • 12.2 Asthma Reliever (Rescue) Medications Distributors
    • 12.3 Asthma Reliever (Rescue) Medications Downstream Customers

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:

      Market Insights
      Due to the COVID-19 pandemic, the global Asthma Reliever (Rescue) Medications market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.
      The global main manufacturers of Asthma Reliever (Rescue) Medications include Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals，Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc and Sepracor, Inc, etc. In 2021, the global six largest players have a share approximately % in terms of revenue.
      The North America Asthma Reliever (Rescue) Medications market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the China is % in 2021 and it is predicted that the share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Europe Asthma Reliever (Rescue) Medications landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
      Quick-Relief Medications accounting for % of the Asthma Reliever (Rescue) Medications global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Children segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
      Segment Scope
      An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including sales and revenue forecast data by type and application for the period 2017-2028. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
      Segment by Type
      Quick-Relief Medications
      Long-Term Control Medications
      Segment by Application
      Children
      Adolescent
      Adult
      Regional Scope
      This segment of the report offers a thorough regional study of the global Asthma Reliever (Rescue) Medications market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate, revenue, and sales volume according to the consumption for the period 2017-2028. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
      Key Players
      This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue and sales data of manufacturers for the period 2017-2022. Following is the list of key manufacturers observed in this research study:
      Dulera
      QVAR
      Glaxosmithkline plc
      MAP Pharmaceuticals，Inc
      Merck & Co. Inc
      AstraZeneca plc
      Roche Holdings Ltd
      Genentech Inc
      Sepracor, Inc
      Schering-Plough Corp
      Sanofi-Aventis
      Theravance Inc
      Frequently Asked Questions
      Which application segment captured the leading share in the Asthma Reliever (Rescue) Medications market?
      How fragmented is the Asthma Reliever (Rescue) Medications market?
      Which are the key growth drivers in the Asthma Reliever (Rescue) Medications market?
      Which are the top strategies undertaken by the Asthma Reliever (Rescue) Medications market players?
      Which technological trends are likely to affect the Asthma Reliever (Rescue) Medications market?
      What is the expected Asthma Reliever (Rescue) Medications market size by 2028?
      Which companies are dominating the Asthma Reliever (Rescue) Medications market?
      Which region is projected to witness the fastest growth in the future?
      What factors are restraining the Asthma Reliever (Rescue) Medications market growth?
      Which are the emerging companies in the Asthma Reliever (Rescue) Medications market?
      Buy now